IRadimed Corporation (IRMD) has a market capitalization of $1.2B and trades at $93.56. The 52-week range is 47.478-107.9.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 52.9, Earnings Per Share (EPS) of $1.77, annual revenue of $83.81M.
The stock has a beta of 1.12, a last dividend of $1.2100, operates in the Healthcare sector.